Australia is globally recognised for its world-class research infrastructure, streamlined regulatory pathways, and highly skilled workforce—making it an ideal destination for clinical trials. With rapid ethics and regulatory approval processes, access to diverse patient populations, and a strong track record of high-quality data, Australia offers biotech and pharmaceutical companies a cost-effective and efficient environment to accelerate innovation and bring new therapies to market faster.
Why Start in South Australia for Clinical Trials?
South Australia offers a unique combination of clinical excellence, collaborative research networks, and streamlined trial processes. With access to state-of-the-art facilities, leading hospitals, and a supportive government ecosystem, South Australia enables faster trial start-up times and high-quality patient recruitment. The state’s cost-effectiveness, centralised health data, and experienced investigators make it an ideal launchpad for early-phase to late-stage clinical trials—helping sponsors de-risk and accelerate their pathway to market.
South Australia offers Australia’s most connected and experienced clinical trial ecosystem, enabling faster trial start-up in just 5–6 weeks thanks to streamlined ethics approval and strong local infrastructure. The state’s advanced and collaborative environment supports efficient, low-risk trial delivery through expert partners and end-to-end support. This globally unique ecosystem helps maximise value, innovation, and success for clinical trial sponsors.
Launching clinical trials in South Australia lets you leverage Australia’s key advantages:
Speed: Fast-track your trial with an efficient regulatory system—no IND required and save up to a year on timelines.
Quality: Generate globally accepted, high-quality data suitable for FDA, EMA, HMRA, and PDMA submissions.
Value: Benefit from a 43.5% R&D tax incentive to significantly reduce costs.
South Australia offers a world-class, fully integrated clinical trial ecosystem, featuring:
Key opinion leaders and research organisations
Accredited clinical sites (e.g., Lyell McEwin Hospital)
Streamlined ethics processes
Regulated bioanalysis and toxicology services
Contract research and development organisations (CROs & CDMOs)
Comprehensive R&D support, tax incentives, and corporate services
Drug storage and global distribution capabilities
South Australia is a connected clinical trials ecosystem for efficient, high-quality health innovation.
Australia’s most experienced providers operate in South Australia, creating the nation’s most comprehensive, connected and supportive clinical trial ecosystem providing
leadership across the entire supply chain.
South Australia’s collaborative ecosystem connects deep clinical research, manufacturing and an end-to-end clinical trial supply chain with world-class infrastructure and digital capabilities for drug development, advanced manufacturing and health innovation.
As a strategic entry point for exploring the Australian trials sector, connecting with the expertise in South Australia provides an efficient pathway to clinical trial conduct.
The Department of State Development has prepared an overview of the South Australia’s Clinical Trial ecosystem.
Discover | SA's Clinical Trials Ecosystem
South Australia’s collaborative ecosystem connects deep clinical research, manufacturing and an end-to-end clinical trial supply chain with world-class infrastructure and digital capabilities for drug development, advanced manufacturing and health innovation.
As a strategic entry point for exploring the Australian trials sector, the South Australian ecosystem and expertise provides an efficient pathway to clinical trial conduct.
The Department of State Development has prepared an overview of the South Australia’s Clinical Trial ecosystem.
Explore | End-to-End Capabilities
Clinical trials data accepted by global regulatory agencies
World leading innovation in artificial intelligence, augmented and virtual reality and machine learning (AI, AR/VR/ ML) quantum, data analytics and cyber security
Statewide electronic medical record linked to Australia’s largest pathology and medical imaging providers
More than 150 health companies, 4000 researchers, world leading hospitals, and health expertise within a 20-minute radius.
Supporting companies maximise R & D activities.
Life sciences converging in priority areas including space, defence, and biotech innovations.
Industry Development Officer
santhni.subramaniam@mtpconnect.org.au
0412 266 317
Administration and Operations Manager
pia.vogrin@mtpconnect.org.au
0419 853 614
